GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Equity-to-Asset

Biovica International AB (OSTO:BIOVIC B) Equity-to-Asset : 0.86 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biovica International AB's Total Stockholders Equity for the quarter that ended in Jan. 2024 was kr136.03 Mil. Biovica International AB's Total Assets for the quarter that ended in Jan. 2024 was kr158.32 Mil. Therefore, Biovica International AB's Equity to Asset Ratio for the quarter that ended in Jan. 2024 was 0.86.

The historical rank and industry rank for Biovica International AB's Equity-to-Asset or its related term are showing as below:

OSTO:BIOVIC B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.47   Med: 0.89   Max: 0.96
Current: 0.86

During the past 9 years, the highest Equity to Asset Ratio of Biovica International AB was 0.96. The lowest was 0.47. And the median was 0.89.

OSTO:BIOVIC B's Equity-to-Asset is ranked better than
77.68% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs OSTO:BIOVIC B: 0.86

Biovica International AB Equity-to-Asset Historical Data

The historical data trend for Biovica International AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Equity-to-Asset Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.86 0.87 0.95 0.82 0.81

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.81 0.79 0.78 0.86

Competitive Comparison of Biovica International AB's Equity-to-Asset

For the Biotechnology subindustry, Biovica International AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Equity-to-Asset falls into.



Biovica International AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biovica International AB's Equity to Asset Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Equity to Asset (A: Apr. 2023 )=Total Stockholders Equity/Total Assets
=138.635/172.288
=0.80

Biovica International AB's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )=Total Stockholders Equity/Total Assets
=136.029/158.32
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biovica International AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines